If you read poster Cardios post... Hikma can state on the label ....For treating very high triglycerides only ....and insurers will still substitute generic V for brand V for lowering cardiovascular risk .
Your post is just a guideline Hikma will use to avoid liability
May slow / delay their entry ... but as it stands ... may not prevent it
Market Data 
Markets 
AI
